TipRanks on MSN
Dyne Therapeutics announces upsized public offering
An announcement from Dyne Therapeutics ( ($DYN) ) is now available. On December 9, 2025, Dyne Therapeutics announced the pricing of an upsized ...
Hillary Swank made the shocking outburst to Jada Bafus, who was taking her two dying sons on a trip to Disneyland in Anaheim.
Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly ...
Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...
The Muscular Dystrophy Association (MDA) today announced more than $2.7 million in new research grants to advance groundbreaking discoveries across multiple neuromuscular diseases, including ...
Sara Martin, who was raised in Nahant, is currently training to run the 2026 Boston Marathon to bring awareness to the Muscular Dystrophy Association. She has raised $4,807 thus far. For Martin, the ...
The effects allowed these minors who could sit but not stand to move like they've never done before, including walking and ...
Kids and teenagers with spinal muscular atrophy had more mobility after receiving a single-dose gene replacement therapy, ...
The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal ...
A single-dose gene replacement therapy is found to improve movement ability in children over 2 years of age and teenagers with spinal muscular atrophy, according to research published in Nature ...
Discusses Positive Topline Results From DELIVER Registrational Expansion Cohort in Duchenne Muscular Dystrophy December ...
The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results